Announcement on Implementation of Dividend Distribution for 2024
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Dividend Distribution for 2024
Filed with SSE · · 3 pages · Chinese
Release
Shandong Lukang Pharmaceutical Co., Ltd. on 6ix
Earlier from Shandong Lukang Pharmaceutical
- Indicative Announcement on Replying to the Review Inquiry Letter of Application Documents for Issuing Shares to Specific Objects and Updates of Application Documents such as Prospectus
- Announcement on Subsidiary's Drug Passing Generic Drug Consistency Evaluation
- Announcement on the Progress of Receiving Land Collection and Storage Compensation for the Southern Factory Area
- Reply to SSE Inquiry Letter on Ex Post Audit of the Company's 2024 Annual Report
- Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction
Later from Shandong Lukang Pharmaceutical
- Announcement on Reply to the Review Inquiry Letter of Application Documents for Issuance of Shares to Specific Objects by Shandong Lukang Pharmaceutical Co., Ltd. (Revised Draft)
- Announcement on Obtaining Drug Registration Certificate and Approval Notice for Chemical Active Pharmaceutical Ingredient Market Application
- Semi-annual Earnings Preannouncement for 2025
- Indicative Announcement on Reply Update to Letter of Review and Inquiry on Application Documents for Shares Issuance to Specific Objects
- Announcement on Cefuroxime Axetil for Suspension Passing Consistency Evaluation
Follow Shandong Lukang Pharmaceutical into a list and get an email when it puts out news.
Follow Shandong Lukang Pharmaceutical